No Result
View All Result
Success American Investors
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Success American Investors
No Result
View All Result
Home Editor's Pick

The Shutdown Deal: Kicking the Can Down the Road

by
November 11, 2025
in Editor's Pick
0
The Shutdown Deal: Kicking the Can Down the Road
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Dominik Lett

On November 9, Senate Republicans reached a deal with eight Democratic senators to end the government shutdown. Although Congress and the president have yet to formally approve the package, it seems likely that the longest shutdown in US history will soon end.

Predictably, the deal is a mixed bag that punts most of the hard decisions to the coming months. Democrats agreed to pass full-year appropriations for the Department of Agriculture, Veterans Affairs, military construction, and legislative operations, with remaining agencies funded on a temporary basis through January 30. In exchange, Senate Majority Leader John Thune promised a December vote on the expiring enhanced Obamacare subsidies. The deal also walks back executive branch reductions-in-force (RIFs) that took place over the shutdown and cracks down on the hemp industry.

That’s hardly a deal that free-market-minded individuals should celebrate, but few bipartisan deals ever are.

For those negatively impacted by Washington’s shutdown theatrics—from air travelers to SNAP beneficiaries—the shutdown deal will be a welcome relief from government-induced pain. However, the deal largely papers over the most difficult questions: full-year appropriations and Obamacare. On those two issues, beware congressional profligacy.

Obamacare

Following last week’s disastrous electoral performance and with midterms on the horizon, moderate congressional Republicans may feel tempted to cave to Democrats’ demands to extend pandemic-era plus-ups for Obamacare subsidies. Doing so would be a mistake, both fiscally and for health care markets.

Locking in the “enhanced ACA subsidies” would add roughly $488 billion in new spending over the next decade, significantly boost the deficit, and make permanent what was originally a temporary, crisis-driven plus-up. This costly, deficit-financed federal intervention is also an inefficient, wasteful use of taxpayer funds because it subsidizes insurance companies, well-off Americans, and low-value health care consumption. Just as troubling, these credits act as a bailout for bankrupt states and cities—disproportionately in Democratic jurisdictions—allowing them to push early retirees onto Obamacare at federal taxpayers’ expense.

Legislators should let the subsidies expire and reduce costs by expanding supply, including by deregulating health insurance and freeing individuals to get better, more affordable coverage.

Appropriations

If the three proposed full-year appropriations bills are any indication, expect little in the way of real spending restraint come January. For Veterans Affairs and military construction, base discretionary spending increases from $146.6 billion in FY25 to $153.3 billion in FY26. Legislative branch spending also increases year over year, from $6.7 billion in FY25 to $7.2 billion in FY26. Agriculture spending, meanwhile, remains roughly flat compared to last year, at $26.7 billion for FY26.

Should Congress pursue a full-year continuing resolution for temporarily funded agencies, the deal would result in $1.68 trillion in total discretionary spending for FY26.

By and large, this deal continues current spending habits or increases them, a far cry from real restraint. Many of the more promising spending cuts contained in the president’s FY26 budget are not reflected in these bills. That’s a disappointing, if not predictable, result from a spendthrift Congress.

Rather than kicking the can down the road, Congress should pair full-year discretionary appropriations with budget-process reform, restoring binding discretionary caps, curbing the abuse of emergency designations, and cutting spending to pre-pandemic levels. Until that happens, any new funding deal will amount to a continuation of Biden-era spending (or worse). With $2 trillion deficits, Congress desperately needs to credibly signal fiscal restraint. That starts with good fiscal planning.

Unfortunately, as Senator Rand Paul warned, Congress plans to entirely waive the existing statutory requirements to offset new borrowing under Pay-As-You-Go (PAYGO). Under PAYGO, deficit-financed laws trigger automatic offsetting spending reductions spread over the subsequent five to ten years. Because Congress authorized $3.4 trillion in new borrowing through the One Big Beautiful Bill Act (OBBBA), PAYGO requires that future spending be automatically reduced by a corresponding amount. By wiping the PAYGO scorecard clean and avoiding planned automatic offsets, Congress is officially blessing the massive deficit impact of the OBBBA. The deal also sneaks in $2.1 billion in new mandatory spending increases—mostly for health care—which Congress also excludes from the PAYGO scorecard. Note that PAYGO rules only apply to direct spending and revenues—not discretionary appropriations.

Wiping the PAYGO scorecard isn’t particularly unusual—Congress routinely skirts the fiscal rules it writes for itself—but it doesn’t bode well for our fiscal outlook.

Ending the shutdown is good for America. Ending the spend-now, reckon-later habit will be a much more difficult task, but a more essential one.

Previous Post

Six million small firms urge COP leaders to unlock finance and incentives for green growth

Next Post

Why Aluminium Doors Are The B2B Material Of Choice For New Generational Commercial Buildings

Next Post
Why Aluminium Doors Are The B2B Material Of Choice For New Generational Commercial Buildings

Why Aluminium Doors Are The B2B Material Of Choice For New Generational Commercial Buildings

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

February 14, 2024

New working paper: “Shifting Perspectives: An Updated Survey of Environmental and Natural Resource Economists”

May 5, 2025

Last Day to Give in 2023!

December 31, 2023
Idaho Bucks Managed Care Trend

Idaho Bucks Managed Care Trend

December 5, 2023

“NatWest Partners with GIM to Fuel Worldwide Expansion in Graphene, AI, and Robotics through Initial Lending Agreement”

0

0

0

0

“NatWest Partners with GIM to Fuel Worldwide Expansion in Graphene, AI, and Robotics through Initial Lending Agreement”

December 8, 2025

As UK Confronts Cyber Emergencies, Offensive Security Takes on Vital Role

December 8, 2025

Orangutan Surrogacy Program Fueled by Generosity and Compassion

December 8, 2025

International Consortium Makes Strides in Advancing Laser Power Transmission Technology for Startup

December 8, 2025

Recent News

“NatWest Partners with GIM to Fuel Worldwide Expansion in Graphene, AI, and Robotics through Initial Lending Agreement”

December 8, 2025

As UK Confronts Cyber Emergencies, Offensive Security Takes on Vital Role

December 8, 2025

Orangutan Surrogacy Program Fueled by Generosity and Compassion

December 8, 2025

International Consortium Makes Strides in Advancing Laser Power Transmission Technology for Startup

December 8, 2025

Disclaimer: SuccessAmericanInvestors.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.